Clinical Trial Update: The Adult Antiretroviral Treatment and Resistance Study (Tshepo) [Phase 3]

View source ↗

Summary

The Tshepo Phase 3 trial of adult antiretroviral treatment and resistance, sponsored by Harvard School of Public Health, has completed; it concerns AIDS and HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: AIDS, HIV Infection | Phase 3 | Status: COMPLETED